See analyst estimates and all valuation multiples for Health & Beauty
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $476B | 7.8x | 18.2x | |
| $407B | 4.7x | 17.1x | |
| $240B | 4.7x | 19.4x | |
| $183B | 2.7x | 12.5x | |
| $85.3B | 4.2x | 17.3x | |
| $84.8B | 1.6x | 7.6x | |
| $66.1B | 3.5x | 12.6x | |
| $60.0B | 8.5x | 36.9x | |
| $57.5B | 3.9x | 15.4x | |
| $46.9B | 8.9x | 38.5x | |
| $43.8B | 2.9x | 13.1x | |
| $42.5B | 2.9x | 20.0x | |
| $41.0B | 4.3x | 17.5x | |
| $38.3B | 1.6x | 8.7x | |
| $32.4B | 2.7x | 17.8x | |
| $26.4B | 4.3x | 18.8x | |
| $24.3B | 2.1x | 12.1x | |
| $23.7B | 1.6x | 8.5x | |
| $21.7B | 2.1x | 6.0x | |
| $18.8B | 1.8x | 11.6x | |
| $14.0B | 8.4x | 40.7x | |
| $12.8B | 2.1x | 14.3x | |
| $10.9B | 7.8x | 43.6x | |
| $10.8B | 7.1x | 28.3x | |
| $10.7B | 1.8x | 9.0x | |
| $9.7B | 6.8x | 36.2x | |
| $9.5B | 1.6x | 15.0x | |
| $9.3B | 1.5x | 8.7x | |
| $7.3B | 7.4x | 28.6x | |
| $6.6B | 10.0x | 31.2x | |
| $6.3B | 2.2x | 14.3x | |
| $5.6B | 3.7x | 18.3x | |
| $5.1B | 0.9x | 5.0x | |
| $4.8B | 1.1x | 6.6x | |
| $4.8B | 2.3x | 12.7x | |
| $4.7B | 11.2x | 34.0x | |
| $4.7B | 1.6x | 6.9x | |
| $4.3B | 3.8x | 11.6x | |
| $4.2B | 1.3x | 7.2x | |
| $4.0B | 1.3x | 7.9x | |
| $4.0B | 8.2x | 31.9x | |
| $3.7B | 2.3x | 12.3x | |
| $3.4B | 1.6x | 9.7x | |
| $3.3B | 0.7x | 6.1x | |
| $3.2B | 3.7x | 9.0x | |
| $3.1B | 2.6x | 16.1x | |
| $3.1B | 2.1x | 10.3x | |
| $2.9B | 9.0x | 33.5x | |
| $2.9B | 0.8x | 5.5x | |
| $2.8B | 1.0x | 8.2x | |
| $2.7B | 1.2x | 8.8x | |
| $2.6B | 1.1x | 5.5x | |
| $2.4B | 2.3x | 10.4x | |
| $2.4B | 3.0x | 21.6x | |
| $2.4B | 1.1x | 7.9x | |
| $2.3B | 0.5x | 6.5x | |
| $2.2B | 5.6x | 16.3x | |
| $2.2B | 5.2x | 19.5x | |
| $2.1B | 3.6x | 17.7x | |
| $2.0B | 1.2x | 10.4x | |
| $2.0B | 1.7x | 12.5x | |
| $1.8B | 2.4x | 12.2x | |
| $1.8B | 1.0x | 7.6x | |
| $1.8B | 2.6x | 12.3x | |
| $1.8B | 0.8x | 9.3x | |
| $1.7B | 6.3x | 17.8x | |
| $1.6B | n/a | n/a | |
| $1.5B | 1.2x | 8.1x | |
| $1.4B | 1.8x | 7.4x | |
| $1.3B | 0.7x | 6.2x | |
| $1.1B | 2.7x | 12.4x | |
| $1.1B | 1.6x | 10.7x | |
| $1.1B | 0.3x | 2.4x | |
| $1.1B | 0.5x | 4.7x | |
| $1.0B | 4.3x | 60.5x | |
| $977M | 2.1x | 10.3x | |
| $931M | 1.2x | 6.3x | |
| $911M | 7.2x | 27.3x | |
| $907M | 0.8x | 7.5x | |
| $902M | 1.1x | 5.6x | |
| $887M | n/a | n/a | |
| $803M | 1.9x | 11.2x | |
| $728M | n/a | n/a | |
| $653M | n/a | n/a | |
| $589M | 0.8x | 6.7x | |
| $518M | 3.0x | 12.1x | |
| $505M | n/a | n/a | |
| $456M | 0.3x | n/a | |
| $395M | 1.5x | 18.0x | |
| $389M | 1.3x | -18.4x | |
| $345M | n/a | n/a | |
| $325M | 6.3x | 24.0x | |
| $324M | 1.6x | -34.7x | |
| $299M | 1.0x | 8.0x | |
| $285M | n/a | n/a | |
| $283M | n/a | n/a | |
| $257M | 0.7x | 11.6x | |
| $254M | n/a | n/a | |
| $253M | 1.8x | 7.7x | |
| $230M | 0.5x | 6.5x | |
| $201M | 1.0x | 9.9x | |
| $193M | 0.4x | 11.3x | |
| $192M | 0.9x | 4.0x | |
| $185M | 2.2x | 13.1x | |
| $155M | 0.8x | 5.6x | |
| $150M | 2.3x | 8.5x | |
| $127M | 0.5x | 5.9x | |
| $115M | n/a | n/a | |
| $112M | 0.5x | 4.5x | |
| $83.8M | n/a | n/a | |
| $70.8M | 0.3x | 7.4x | |
| $60.0M | 2.3x | 9.7x | |
| $42.6M | 0.9x | n/a | |
| $42.4M | n/a | n/a | |
| $41.8M | n/a | n/a | |
| $40.5M | n/a | n/a | |
| $39.8M | n/a | n/a | |
| $30.8M | 2.5x | n/a | |
| $30.3M | n/a | n/a | |
| $20.4M | 1.1x | -12.0x | |
| $19.9M | n/a | n/a | |
| $17.4M | n/a | n/a | |
| $17.2M | n/a | n/a | |
| $13.0M | n/a | n/a | |
| $5.0M | n/a | n/a | |
| $0.9M | n/a | n/a | |
| -$0.3M | n/a | n/a | |
| -$41.8M | -0.1x | -69.7x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Health & Beauty